Healthcare -
Biotechnology - NASDAQ - US
$ 0.356
-49.1 %
$ 129 M
Market Cap
-0.48
P/E
LXRX - CASH & EQUIVALENTS
Cash & Equivalents LXRX - Lexicon Pharmaceuticals, Inc.
22.5 M
LAST VALUE
-40.78%
2 YEAR CAGR
-32.48%
5 YEAR CAGR
-16.04%
10 YEAR CAGR